Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia

Overview

Co-design of a home-based anaemia monitoring system with participants who have previous diagnosis of anaemia.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 15, 2021

Detailed Description

The device/ monitoring system being developed is called Aptus home. Aptus home measures the haemoglobin and haematocrit levels in blood from a single drop of blood. By measuring these blood parameters, participants are able to monitor anaemia in participants' homes. The use of the device will take place in the participant's home to simulate what the investigators believe will be the ideal location for people who would prefer to self-manage their condition. This study is a unique opportunity to gain feedback on the future design and development of a home-based monitoring system through user evaluation. As this is an adaptive/ iterative study design, this will give the Sponsor the opportunity to make changes to the user interface and user platform based on the feedback received from the end user.

Interventions

  • Device: Blood measurement
    • Single fingerprick to measure haemoglobin and haematocrit measurements using the Aptus Home, anaemia home monitoring system.

Clinical Trial Outcome Measures

Primary Measures

  • Qualitative capture of user feedback- Questionnaires
    • Time Frame: 14 months
    • User feedback gathered from participants using the anaemia monitoring device in participants’ homes will be used to inform the changes necessary to develop a successful home-based anaemia monitoring system.
  • Qualitative capture of user feedback- focus groups
    • Time Frame: 14 months
    • User feedback gathered from participants using the anaemia monitoring device in participants’ homes will be used to inform the changes necessary to develop a successful home-based anaemia monitoring system.

Participating in This Clinical Trial

Inclusion Criteria

  • Prior diagnosis of anaemia – Commitment to perform finger pricking to use the device every two weeks and complete 2 monthly questionnaires – Participant's willingness to participate in 1 to 1 interviews and, or focus groups – Understands and has a good level of spoken and written English Exclusion Criteria:

  • No prior diagnosis of anaemia – Not committed to perform two weekly finger pricks to use device and complete 2 monthly questionnaires – Unwilling to attend interviews and focus groups – Doesn't have a good level of written and spoken English

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Entia Ltd
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.